Literature DB >> 23007753

Dielectric and Mössbauer studies of ferroelectric and magnetic phase transitions in A-site and B-site substituted multiferroic PbFe0.5Nb0.5O3.

Igor P Raevski1, Stanislav P Kubrin, Svetlana I Raevskaya, Sergey A Prosandeev, Maria A Malitskaya, Victor V Titov, Dmitry A Sarychev, Aleksei V Blazhevich, Irina N Zakharchenko.   

Abstract

In the present study, we diluted either A- or B- sublattice of perovskite multiferroic PbFe(0.5)Nb(0.5)O(3) (PFN) and studied the changes of the magnetic and ferroelectric phase transition temperatures and dielectric properties caused by such dilution. Dielectric studies of PFN single crystals show that, in contrast to the commonly adopted view, the ferroelectric phase transition in PFN is non-diffused and the relaxor-like behavior usually observed in ceramic samples has an extrinsic nature. A-site substitutions (Ba, Ca) lead to the smearing of the permittivity-temperature maximum, lowering its maximum temperature, T(m) and inducing relaxor behavior. B-site diluting of PFN by Ti increases T(m) and only slightly affects the permittivity maximum diffuseness. Both A-site and B-site substitutions in PFN lead to lowering of its Neel temperature, T(N). However, above a certain compositional threshold, fast lowering of T(N) stops and a new magnetic state with comparatively high (~50K) transition temperature becomes stable in a rather wide compositional range.

Entities:  

Year:  2012        PMID: 23007753     DOI: 10.1109/TUFFC.2012.2399

Source DB:  PubMed          Journal:  IEEE Trans Ultrason Ferroelectr Freq Control        ISSN: 0885-3010            Impact factor:   2.725


  1 in total

1.  Elastic and anelastic relaxation behaviour of perovskite multiferroics II: PbZr0.53Ti0.47O3 (PZT)-PbFe0.5Ta0.5O3 (PFT).

Authors:  J A Schiemer; I Lascu; R J Harrison; A Kumar; R S Katiyar; D A Sanchez; N Ortega; C Salazar Mejia; W Schnelle; H Shinohara; A J F Heap; R Nagaratnam; S E Dutton; J F Scott; B Nair; N D Mathur; M A Carpenter
Journal:  J Mater Sci       Date:  2016-09-09       Impact factor: 4.220

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.